CERTIFICATE

IMPACT FACTOR 2021

Subject Area

  • Life Sciences / Biology
  • Architecture / Building Management
  • Asian Studies
  • Business & Management
  • Chemistry
  • Computer Science
  • Economics & Finance
  • Engineering / Acoustics
  • Environmental Science
  • Agricultural Sciences
  • Pharmaceutical Sciences
  • General Sciences
  • Materials Science
  • Mathematics
  • Medicine
  • Nanotechnology & Nanoscience
  • Nonlinear Science
  • Chaos & Dynamical Systems
  • Physics
  • Social Sciences & Humanities

Why Us? >>

  • Open Access
  • Peer Reviewed
  • Rapid Publication
  • Life time hosting
  • Free promotion service
  • Free indexing service
  • More citations
  • Search engine friendly

Serum levels of TNF-α and IL-6 in patients with diabetic nephropathy

Author: 
Nagwa Ebrahim, ABOZEID A. HASSANIEN, MAGDY Mahmud Mohamed and Gamal Ahmed Tawfik
Subject Area: 
Health Sciences
Abstract: 

Background: Diabetic nephropathy (DN) is one of the chronic complications of diabetes mellitus (DM) that cause a common end-stage renal disease (ESRD). Cytokines regulate inflammatory processes in response to the degree of inflammations. Overproduction of pro-inflammatory cytokines such as tumor necrosis factoralpha (TNF-α) and interlukin-6 (IL-6) play a role in the development and progression of DN. Aim: To evaluate the levels of TNF-α and IL-6, and their implication in diagnosis and progression of nephropathy in patients with type 2diabetes mellitus (T2DM). Subjects and Methods: Sixty subjects (45 patients, 15 normal) were selected from Suez city and general hospital in Suez, with mean age43.3±8.2years. They were classified into four groups, Group I:healthy subjects, Group II:T2DMpatients; GroupIII: Nephropathicpatients identified by high level of creatinine in blood and microalbuminurea; and Group IV: Nephropathic patients with T2DM as identified by high level of creatinine and glucose in blood and microalbuminurea. Blood and urine samples were collected and tested for fasting and postprandial blood glucose (PBG) level, glycosylated hemoglobin (HbA1C), liver and kidney function tests. In addition, serum TNF-α, and IL-6levels were measured by Enzyme Linked Immune Sorbent Assay (ELISA). Results: The level of IL-6 was significantly increased (p<0.05) in nephropathy and DN groups compared to control and T2DM groups with a significant positive correlation between its level and the duration of diabetes in DN group and significant negative correlation between its level and duration of diabetes in T2DM group. On the other side, TNF-α levels were significantly decreased(p<0.05) in both nephropathy and DN groups compared with control and T2DM groups which was not correlate to the duration of diabetes in either T2DM or DN groups. Conclusion: Tracking the levels of IL-6 cytokine in T2DM patients could be used as a marker for progression to DN patients.

PDF file: 

CALL FOR PAPERS

 

ONLINE PAYPAL PAYMENT

IJMCE RECOMMENDATION

Advantages of IJCR

  • Rapid Publishing
  • Professional publishing practices
  • Indexing in leading database
  • High level of citation
  • High Qualitiy reader base
  • High level author suport

Plagiarism Detection

IJCR is following an instant policy on rejection those received papers with plagiarism rate of more than 20%. So, All of authors and contributors must check their papers before submission to making assurance of following our anti-plagiarism policies.

 

EDITORIAL BOARD

CHUDE NKIRU PATRICIA
Nigeria
Dr. Swamy KRM
India
Dr. Abdul Hannan A.M.S
Saudi Arabia.
Luai Farhan Zghair
Iraq
Hasan Ali Abed Al-Zu’bi
Jordanian
Fredrick OJIJA
Tanzanian
Firuza M. Tursunkhodjaeva
Uzbekistan
Faraz Ahmed Farooqi
Saudi Arabia
Eric Randy Reyes Politud
Philippines
Elsadig Gasoom FadelAlla Elbashir
Sudan
Eapen, Asha Sarah
United State
Dr.Arun Kumar A
India
Dr. Zafar Iqbal
Pakistan
Dr. SHAHERA S.PATEL
India
Dr. Ruchika Khanna
India
Dr. Recep TAS
Turkey
Dr. Rasha Ali Eldeeb
Egypt
Dr. Pralhad Kanhaiyalal Rahangdale
India
DR. PATRICK D. CERNA
Philippines
Dr. Nicolas Padilla- Raygoza
Mexico
Dr. Mustafa Y. G. Younis
Libiya
Dr. Muhammad shoaib Ahmedani
Saudi Arabia
DR. MUHAMMAD ISMAIL MOHMAND
United State
DR. MAHESH SHIVAJI CHAVAN
India
DR. M. ARUNA
India
Dr. Lim Gee Nee
Malaysia
Dr. Jatinder Pal Singh Chawla
India
DR. IRAM BOKHARI
Pakistan
Dr. FARHAT NAZ RAHMAN
Pakistan
Dr. Devendra kumar Gupta
India
Dr. ASHWANI KUMAR DUBEY
India
Dr. Ali Seidi
Iran
Dr. Achmad Choerudin
Indonesia
Dr Ashok Kumar Verma
India
Thi Mong Diep NGUYEN
France
Dr. Muhammad Akram
Pakistan
Dr. Imran Azad
Oman
Dr. Meenakshi Malik
India
Aseel Hadi Hamzah
Iraq
Anam Bhatti
Malaysia
Md. Amir Hossain
Bangladesh
Ahmet İPEKÇİ
Turkey
Mirzadi Gohari
Iran